Related Experiment Video
Updated: Jun 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Chasing clot: thrombophilic states and the interventionalist
Karim Valji1, Michael Linenberger
1Department of Radiology, University of Washington, 1959 Northeast Pacific Street, Box 357115, Seattle, WA 98195, USA. kvalji@u.washington.edu
Thrombophilia, a risk factor for blood clots, involves genetic and acquired factors. Understanding these conditions is crucial for interventional radiologists managing patients with venous thromboembolism and arterial disease.
Area of Science:
- Medical Science
- Hematology
- Radiology
Background:
- Thrombophilia is a significant risk factor in idiopathic venous thromboembolism.
- It may also contribute to arterial thrombotic disease.
- Both inherited and acquired factors influence thrombotic risk.
Purpose of the Study:
- To review the disorders and prevalence of thrombophilia.
- To provide guidelines for managing thrombophilia cases.
- To highlight the importance of thrombophilia knowledge for interventional radiologists.
Main Methods:
- Literature review of thrombophilia disorders.
- Analysis of prevalence data for genetic and acquired thrombophilias.
- Synthesis of current understanding of thrombotic risk factors.
Main Results:
- Common genetic thrombophilias confer a modest risk.
- Less common thrombophilias are associated with a higher risk of pathological clot formation.
- Most thrombotic events result from combined inherited and acquired risks.
Conclusions:
- Understanding thrombophilia is essential for interventional radiologists.
- Management strategies should consider additive predisposing risks.
- This review offers guidance for handling patients with thrombophilia.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
